Close Menu

NEW YORK (GenomeWeb) – Embark Veterinary announced today that it has raised $4.5 million in order to expand its suite of canine genetic tests. The consumer genomics company said it has also relocated its headquarters.

According to Embark, its latest round of financing was led by Cambridge, Massachusetts-based Founder Collective, San Francisco-based Freestyle Capital, and Third Kind, a New York venture capital fund.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.